Real-life safety and effectiveness outcomes of teriflunomide in patients with relapsing–remitting multiple sclerosis: The TERICAM study
Autor: | Martínez-Ginés, M.L., García-Domínguez, J.M., Cuello, J.P., Meca-Lallana, V., Aguirre, C., Costa-Frossard, L., Monreal, E., Sainz de la Maza, S., Salgado-Cámara, P., Labiano-Fontcuberta, A., Fernández-Cabredo, L., Aladro-Benito, Y., Canelo, L.B., Valle, O.Sánchez-del, Blasco, M.R., Sabin-Muñoz, J., Caminero-Rodríguez, A.B., Gracia-Gil, J., Fernandez-Diaz, E., Mendoza-Rodríguez, A., Gómez-Moreno, M., Orviz-García, A., Moreno-Torres, I., Casanova-Peño, L.I., Lozano-Ros, A. |
---|---|
Zdroj: | In Neurology Perspectives October-December 2023 3(4) |
Databáze: | ScienceDirect |
Externí odkaz: |